China’s central bank upbeat on Q2 GDP growth, confident on 2023 targets

BEIJING (Reuters) -China’s economic growth is expected to be “relatively high” in the second quarter compared to the prior year, mainly due a low base of comparison, while consumer inflation is projected to be above 1% by December, the central bank governor said. As rising interests rates and inflation squeeze demand in the United States…

Read More

Whoosh! Global equity funds see biggest weekly outflows in 12 weeks

(Reuters) – Global equity funds posted outflows for the eighth consecutive week in the seven days leading up to June 7, as concerns over stubbornly high inflation and sluggish economic growth prompted investors to pull back from riskier assets. According to data from Refinitiv Lipper, investors withdrew a net $18.84 billion from global equity funds,…

Read More

Swiss government says it has reached agreement with UBS on loss guarantees

ZURICH (Reuters) – The Swiss government has signed an agreement with UBS to cover up to 9 billion Swiss francs ($10.01 billion) in losses from its emergency takeover of Credit Suisse, the finance ministry said on Friday. “To make the takeover possible, the government granted UBS a guarantee for any losses incurred in the liquidation…

Read More

BOJ’s Ueda flags shift in corporate pricing, upward inflation bias

By Leika Kihara TOKYO (Reuters) -Bank of Japan Governor Kazuo Ueda said the country’s corporate price-setting behaviour was showing changes that could work to push up inflation more than expected, suggesting the economy was making steady progress toward hitting its 2% price target. But he stressed anew the central bank’s resolve to keep ultra-loose policy,…

Read More

AstraZeneca signs $2 billion agreement with Quell to develop cell therapies

(Reuters) – AstraZeneca said on Friday it had signed an agreement with Quell Therapeutics potentially worth more than $2 billion to develop cell therapies that could cure autoimmune diseases. The agreement includes developing, manufacturing and commercialising cell therapies that have the potential to be curative in type 1 diabetes and inflammatory bowel disease indications, the…

Read More

Erdogan names Erkan to head Turkey central bank, policy pivot expected

By Daren Butler and Jonathan Spicer ISTANBUL (Reuters) -President Tayyip Erdogan on Friday appointed Hafize Gaye Erkan, a finance executive in the United States, to head Turkey’s central bank, which is widely expected to reverse course and tighten policy after years of rate cuts and a simmering cost-of-living crisis. Erkan, former co-CEO at First Republic…

Read More